Pfizer wins USFDA approval for IBRANCE to treat men with Metastatic Breast Cancer Farhat Nasim5 April 2019 9:35 AM ISTNew Delhi: Drug maker, Pfizer recently announced that the U.S. Food and Drug Administration (USFDA) has approved a supplemental New Drug Application...
USFDA completes inspection of Lupin Bioresearch Centre Pune Farhat Nasim5 April 2019 9:30 AM ISTThe inspection of Lupin Bioresearch Centre by the United States Food and Drug Administration (USFDA) has been successfully completed without any...
USFDA takes action to combat illegal online sale of opioids including Tramadol Medical Dialogues Bureau5 April 2019 9:15 AM ISTU.S: The U.S. Food and Drug Administration(USFDA) recently announced the issuance of two warning letters to operators of websites that illegally...
Novartis division Alcon spinoff ousts Baer from Swiss benchmark SMI Medical Dialogues Bureau5 April 2019 9:00 AM ISTNovartis has estimated Alcon's value at around 25 billion Swiss francs ($25 billion), while some analysts predict an initial market capitalisation of...
Prices of 21 New Drugs fixed by NPPA; Details Meghna A Singhania4 April 2019 10:00 AM ISTThe NPPA order is likely to affect drug majors including Torrent Pharma, Alkem Laboratories, Zydus Pharmaceuticals, Cadila Healthcare, Mylan, Cipla,...
Emcure launches generic Eribulin at 40 percent lower price in India Farhat Nasim4 April 2019 9:30 AM ISTEmcure Pharmaceuticals will manufacture Eribulin at its plant at Hinjewadi in Pune and market it at a cost which will be approximately 40 per cent...
Novartis division resubmits USFDA application for biosimilar Pegfilgrastim Farhat Nasim4 April 2019 9:15 AM ISTNew Delhi: Novartis division, Sandoz, recently announced resubmission of its Biologics License Application (BLA) for a proposed biosimilar...
Roche extends Spark Therapeutics' offer worth 4.3 billion USD Garima4 April 2019 9:14 AM ISTRoche needs to get at least a majority of outstanding Spark stock for the offer to go through.ZURICH: Roche Holding has extended until May 2 its $4.3...
Family behind OxyContin calls opioid suit false, misleading Medical Dialogues Bureau4 April 2019 9:04 AM ISTBOSTON: Massachusetts authorities created a false picture of the Sackler family's role in promoting OxyContin, the Sacklers said Tuesday in their...
Cigna caps insulin prices at $25 for 30 days Medical Dialogues Bureau4 April 2019 9:00 AM ISTCigna, which bought pharmacy benefits manager Express Scripts last year, said it was partnering with insulin manufacturers to lower copayments to $25...
NPPA revises ceiling price of 847 formulations including Metformin, Atrovastatin; Details Meghna A Singhania3 April 2019 6:08 PM ISTNew Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling prices of 847 formulations under the...
MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens Meghna A Singhania3 April 2019 4:30 PM ISTNew Delhi: After facing trouble with its baby talcum powder amid allegations that it contains asbestos, US healthcare giant Johnson and Johnson (JnJ)...
